ABarginase (ABRAM Therapeutics)

N/A

Report date: 2025/06/12 16:52:35

Base Information

Drug NameABarginase (ABRAM Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionArginase replacements
TargetsArginine
Therapy Area/IndicationsObesityMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHong Kong Polytechnic UniversityChinese University Of Hong Kong (Cuhk)
China Registration ClassN/A

Develop Information

Active CompaniesABRAM Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsObesityMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A